Castle Creek Biosciences Funding & Investors
Castle Creek Biosciences is focused on developing and commercializing novel, personalized gene therapies for rare skin and connective tissue disorders with high unmet need. It was founded in 2015 and headquartered in Pennsylvania, United States.
castlecreekbio.comTotal Amount Raised: $309,424,992
Castle Creek Biosciences Funding Rounds
Series Unknown
$112,800,000
Series Unknown Investors
Fidelity InvestmentsValor Equity PartnersParagon BiosciencesSeries Unknown
$55,000,000
Series Unknown Investors
Paragon BiosciencesFidelity InvestmentsValor Equity PartnersSeries Unknown
$71,800,000
Series Unknown Investors
Valor Equity PartnersFidelity InvestmentsSeries Unknown
$71,800,000
Series Unknown Investors
Valor Equity PartnersFidelity InvestmentsSeries Unknown
$48,000,000
Series Unknown Investors
Fidelity InvestmentsSeries Unknown
$48,000,000
Series Unknown Investors
Fidelity InvestmentsSeries Unknown
$112,800,000
Series Unknown Investors
Fidelity InvestmentsValor Equity PartnersParagon BiosciencesGrant
$1,825,000
Grant Investors
Food and Drug AdministrationGrant
$1,825,000
Grant Investors
Food and Drug AdministrationDebt Financing
$20,000,000
Debt Financing Investors
Horizon Technology FinanceDebt Financing
$20,000,000
Debt Financing Investors
Horizon Technology FinanceSeries Unknown
$55,000,000
Series Unknown Investors
Paragon BiosciencesFidelity InvestmentsValor Equity Partners
Funding info provided by Diffbot.